TrialJournal of human hypertension2006

Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study.

G McInnes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.